Neonc Technologies (NASDAQ:NTHI) Coverage Initiated by Analysts at Alliance Global Partners

Research analysts at Alliance Global Partners began coverage on shares of Neonc Technologies (NASDAQ:NTHI) in a report issued on Tuesday, Marketbeat reports. The brokerage set a “buy” rating and a $13.00 price target on the stock. Alliance Global Partners’ target price points to a potential upside of 143.45% from the company’s previous close.

A number of other equities analysts have also recently weighed in on NTHI. Weiss Ratings reissued a “sell (e+)” rating on shares of Neonc Technologies in a research report on Friday, March 27th. Maxim Group initiated coverage on shares of Neonc Technologies in a research report on Monday. They set a “buy” rating and a $20.00 price target on the stock. Finally, BTIG Research initiated coverage on shares of Neonc Technologies in a research report on Friday, April 24th. They set a “buy” rating and a $15.00 price target on the stock. Three equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Neonc Technologies currently has a consensus rating of “Hold” and a consensus price target of $16.00.

Neonc Technologies Stock Down 2.9%

Shares of NTHI stock opened at $5.34 on Tuesday. Neonc Technologies has a 52-week low of $3.20 and a 52-week high of $12.99. The firm’s 50 day moving average price is $6.34 and its two-hundred day moving average price is $8.16.

Neonc Technologies (NASDAQ:NTHI) last announced its quarterly earnings data on Monday, May 18th. The company reported ($0.38) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.16).

Insider Buying and Selling at Neonc Technologies

In related news, President Amir F. Heshmatpour acquired 20,000 shares of the company’s stock in a transaction that occurred on Thursday, April 2nd. The shares were acquired at an average cost of $6.09 per share, for a total transaction of $121,800.00. Following the completion of the acquisition, the president directly owned 3,012,000 shares in the company, valued at approximately $18,343,080. The trade was a 0.67% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders have acquired 80,700 shares of company stock worth $423,590 over the last quarter.

Institutional Investors Weigh In On Neonc Technologies

A number of hedge funds and other institutional investors have recently made changes to their positions in NTHI. HighPoint Advisor Group LLC raised its holdings in shares of Neonc Technologies by 424.8% during the third quarter. HighPoint Advisor Group LLC now owns 950,232 shares of the company’s stock worth $8,628,000 after acquiring an additional 769,163 shares during the period. Bank of America Corp DE acquired a new stake in shares of Neonc Technologies during the second quarter worth $801,000. Vanguard Group Inc. acquired a new stake in shares of Neonc Technologies during the third quarter worth $1,279,000. 683 Capital Management LLC acquired a new stake in shares of Neonc Technologies during the fourth quarter worth $442,000. Finally, Royal Bank of Canada acquired a new stake in shares of Neonc Technologies during the first quarter worth $247,000.

Neonc Technologies Company Profile

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.